Global Dermatophytic Onychomycosis Treatment Market By Product (Nail Paint and Tablets), By Type (OTC and RX,) By Route Of Administration (Topical and Oral), By Distribution Channel (Healthcare, Hospitality, Commercial, Institutional, Transportation, Industrial, Remediation & Restoration, and Household), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 95278
- Number of Pages: 347
- Format:
-
-
-
- Bausch Health Companies
- Celtic Pharma
- Galderma S.A.
- Johnson & Johnson
- Anacor pharmaceuticals Inc.
- Pfizer Inc Company Profile
- GlaxoSmithKline Plc
- Novartis AG Company Profile
- Topica Pharmaceuticals Inc.
- Bayer AG Company Profile
- Moberg Pharma AB
- Allergen Inc.
- Cipla Limited Company Profile
- Dr. Reddys Laboratories Ltd Company Profile
- Sanofi S.A.
- Merz Pharma.
- Medimetriks Pharmaceuticals Inc.
- NovaBiotics Inc.
- ZimVie Inc.
- Wieland Dental
- Teva Pharmaceutical Industries Ltd. Company Profile
- Cardinal Health Inc.
- Zimmer Biomet
- Lumenis Ltd
- Blueberry Therapeutics
- Viatris Inc.
- Valeant Pharmaceuticals International Inc.
- Almirall S.A.
- Other players.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |